FdaApplication
NDA 020500
Identifiers
- fda_app_no: NDA020500
Properties
| Property | Value |
|---|---|
| applicant_name | GLAXOSMITHKLINE LLC |
| application_type | NDA |
| approval_date | 1995-02-08 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MEPRON | ATOVAQUONE | 750MG/5ML | SUSPENSION;ORAL |
1 product